News from jazz pharmaceuticals plc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 08, 2014, 06:30 ET

Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), priced...

Aug 06, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), intends to...

Aug 05, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter ended June 30, 2014 and updated financial...

Aug 05, 2014, 16:01 ET

Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of its acquisition of rights to defibrotide in the United States (U.S.)...

Aug 04, 2014, 16:10 ET

Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the Canaccord Genuity...

Jul 22, 2014, 16:05 ET

Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 second quarter financial results on Tuesday, August 5,...

Jul 02, 2014, 08:00 ET

Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has signed a definitive agreement with Sigma-Tau Pharmaceuticals, Inc....

Jun 02, 2014, 14:40 ET

Jazz Pharmaceuticals Presents JZP-110 Phase 2b Data For The Treatment Of EDS Symptoms In Adults With Narcolepsy

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented data from the Phase 2b study evaluating JZP-110 (formerly known as ADX-N05) as a...

May 27, 2014, 16:05 ET

Jazz Pharmaceuticals To Present Data On Compound In Sleep Pipeline During APSS Annual SLEEP Meeting

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that new data for the investigational compound JZP-110 (previously ADX-N05) will...

May 19, 2014, 14:00 ET

Jazz Pharmaceuticals Names Russell J. Cox To Position Of Chief Operating Officer

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Russell J. Cox to the newly created position of chief operating officer...

May 13, 2014, 18:15 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...

May 08, 2014, 16:05 ET

Jazz Pharmaceuticals Announces First Quarter 2014 Financial Results

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter ended March 31, 2014 and reaffirmed and updated...

Apr 24, 2014, 16:05 ET

Jazz Pharmaceuticals to Report 2014 First Quarter Financial Results on May 8, 2014

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 first quarter financial results on Thursday, May 8, 2014,...

Apr 01, 2014, 14:56 ET

Jazz Pharmaceuticals und Gentium kündigen die europäische Markteinführung der ersten zugelassenen lebensrettenden Behandlung bei schwerer Lebervenenverschlusskrankheit an

-- Markteinführung von Defitelio®▼ (Defibrotid) während des 40. Jahrestreffens der European Society for Blood and Marrow...

Apr 01, 2014, 14:41 ET
Apr 01, 2014, 03:24 ET

Jazz Pharmaceuticals y Gentium anuncian el lanzamiento de su tratamiento para la enfermedad venooclusiva hepática

- Jazz Pharmaceuticals y Gentium anuncian el lanzamiento comercial europeo de su primer tratamiento para salvar vidas aprobado para la enfermedad...

Mar 31, 2014, 08:00 ET

Jazz Pharmaceuticals And Gentium Announce European Commercial Launch Of First Approved Life-Saving Treatment For Severe Hepatic Veno-Occlusive Disease

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Gentium S.p.A., a Jazz Pharmaceuticals company, today announced the commencement of the European...

Feb 26, 2014, 18:00 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...

Feb 25, 2014, 16:07 ET

Jazz Pharmaceuticals Announces Management Change

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Kathryn Falberg, executive vice president and chief financial officer (CFO), has...

Feb 25, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2013 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter ended December 31, 2013 and...